Clinical Trials · NCT06764056
Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
- Enrollment
- 120
- Start date
- Jan 2025
- Locations
- 1 site, Canada
- Primary endpoint
- Liver Steatosis